Health-related quality of life is impaired in active collagenous colitis

Digestive and Liver Disease

Volumn 43, Issue 2, 2011, Pages 102-109

  Hjortswang, Henrik ^a   Tysk, Curt ^b   Bohr, Johan ^b   Benoni, Cecilia ^c   Vigren, Lina ^c   Kilander, Anders ^d   Larsson, Lasse ^d   Taha, Yesuf ^e   Ström, Magnus ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Collagenous colitis; Health; Health related quality of life; Inflammatory bowel disease (IBD); Microscopic colitis; Quality of life

Indexed keywords

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOATING; COLLAGENOUS COLITIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE DURATION; EDUCATIONAL STATUS; EMOTION; ENERGY; ENTERITIS; FEMALE; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; LEISURE; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; QUESTIONNAIRE; RECTUM HEMORRHAGE; REMISSION; SEXUAL BEHAVIOR; SOCIAL STATUS; SPORT;

ABDOMINAL PAIN; AGED; COLITIS, COLLAGENOUS; CROSS-SECTIONAL STUDIES; DIARRHEA; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SWEDEN;

EID: 78651413985     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.06.004     Document Type: Article

References (29)

1. Lindström C.G. 'Collagenous colitis' with watery diarrhea. A new entity. Pathol Eur 1976, 11:87-89.
2. Tysk C., Bohr J., Nyhlin N., et al. Diagnosis and management of microscopic colitis. World J Gastroenterol 2008, 14:7280-7288.
3. Jessurun J., Yardley J.H., Giardiello F.M., et al. Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathological findings in 15 patients. Hum Pathol 1987, 18:839-848.
4. Bohr J., Tysk C., Eriksson S., et al. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 1996, 39:846-851.
5. Olesen M., Eriksson S., Bohr J., et al. Microscopic colitis: a common diarrheal disease. An epidemiological study in Örebro, Sweden, 1993-1998. Gut 2004, 53:346-350.
6. Agnarsdottir M., Gunnlaugsson O., Orvar K.B., et al. Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci 2002, 47:1122-1128.
7. Pardi D.S., Loftus E.V., Smyrk T.C., et al. The epidemiology of microscopic colitis: a population-based study in Olmsted County, Minnesota. Gut 2007, 56:504-508.
8. Feyen B., Wall G.C., Finnerty E.P., et al. Meta-analysis: budesonide treatment for collagenous colitis. Aliment Pharmacol Therap 2004, 20:745-749.
9. Chande N., McDonald J.W., Macdonald J.K. Interventions for treating collagenous colitis. Cochrane Database Syst Rev 2008, CD003575.
10. Bonderup O.K., Hansen J.B., Birket-Smith L., et al. Budesonide treatment of collagenous colitis: a randomized, double blind, placebo controlled trial with morphometric analysis. Gut 2003, 52:248-251.
11. Miehlke S., Heymer P., Bethke B., et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 2002, 123:978-984.
12. Miehlke S., Madisch A., Bethke B., et al. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Therap 2005, 22:1115-1119.
13. Bonderup O.K., Hansen J.B., Teglbjaerg P.S., et al. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo controlled trial. Gut 2009, 58:68-72.
14. Madisch A., Heymer P., Voss C., et al. Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorect Dis 2005, 20:312-316.
15. Miehlke S., Madisch A., Bethke B., et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2008, 135:1510-1516.
16. Ware J.E., Sherbourne C.D. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-481.
17. McHorney C.A., Ware J.E., Rogers W., et al. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care 1992, 30(Suppl.):MS253-MS265.
18. McHorney C.A., Ware J.E., Raczek A.E. The MOS 36-item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993, 31:247-263.
19. Dupuy H.J. The psychological general well-being (PGWB) index. Assessment of quality of life in clinical trials of cardiovascular therapies 1984, 170-183. Le Jacq Publishing Inc., USA. N.K. Wenger, M.E. Mattson, C.F. Furberg, J. Elinson (Eds.).
20. Guyatt G., Mitchell A., Irvine E.J., et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989, 96:804-810.
21. Irvine E.J., Feagan B., Rochon J., et al. Quality of life: a valid and reliable measure of the therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology 1994, 106:287-296.
22. Drossman D.A., Leserman J., Li Z., et al. The Rating Form of IBD Patient Concerns: a new measure of health status. Psychosom Med 1991, 53:701-712.
23. Sullivan M., Karlsson J., Ware J.E. SF-36 Hälsoenkät: Svensk manual och tolkningsguide [Swedish manual and interpretation guide] 1994, Sahlgrenska University Hospital, Gothenburg.
24. Wiklund I., Karlberg J. Evaluation of quality of life in clinical trials: selecting quality of life measures. Control Clin Trials 1991, 12:S204-216.
25. Hjortswang H., Järnerot G., Curman B., et al. Validation of the inflammatory bowel disease questionnaire (IBDQ) in Swedish patients with ulcerative colitis. Scand J Gastroenterol 2001, 36:77-85.
26. Stjernman H., Grännö C., Bodemar G., et al. Evaluation of the inflammatory bowel disease questionnaire in Swedish patients with Crohn's disease. Scand J Gastroenterol 2006, 41:934-943.
27. Hjortswang H., Ström M., Almeida R.T., et al. Evaluation of the RFIPC, a disease-specific health-related quality of life questionnaire, in Swedish patients with ulcerative colitis. Scand J Gastroenterol 1997, 32:1235-1240.
28. Hjortswang H., Tysk C., Bohr J., et al. Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis 2009, 15:1875-1881.
29. Sullivan M., Karlsson J. The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol 1998, 51:1105-1113.